← Back to Clinical Trials
Recruiting NCT06269081

NCT06269081 Testing Two Interventions to Improve Health Outcomes and Quality of Life Among Rural Older Adults Living With HIV

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06269081
Status Recruiting
Phase
Sponsor Medical College of Wisconsin
Condition HIV
Study Type INTERVENTIONAL
Enrollment 352 participants
Start Date 2024-04-10
Primary Completion 2027-01-31

Eligibility & Interventions

Sex All sexes
Min Age 50 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Supportive-Expressive Peer Social Support Group InterventionIndividual Strengths-Based Case Management Intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 352 participants in total. It began in 2024-04-10 with a primary completion date of 2027-01-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Engagement in HIV medical care and adherence to HIV medications are both essential in improving health outcomes among people living with HIV (PLH), but PLH living in rural areas-who suffer higher mortality rates than their urban counterparts-can confront multiple barriers to care engagement and adherence, especially as they face the logistical, medical, and social challenges associated with aging. This project will test the efficacy of two interventions to determine their impact on HIV health outcomes and quality of life among rural, older PLH living in the Southern U.S. The two interventions, adapted from evidence-based interventions and delivered remotely, are: (1) supportive-expressive peer social support groups and (2) strengths-based case management. We hypothesize that both interventions will increase viral suppression, antiretroviral therapy adherence, and health-related quality of life and decrease depressive symptoms. Results from this study will provide us with tools to improve health outcomes for rural older people living with HIV.

Eligibility Criteria

Inclusion Criteria: * Aged 50 years or greater * Living in a county with a score of .4 or higher on the index of relative rurality (IRR) * Living in Alabama, Arkansas, Delaware, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, Missouri, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, or West Virginia * Living with HIV * Has a telephone at home * Able to provide informed consent Exclusion Criteria: * Not meeting eligibility criteria described above

Contact & Investigator

Central Contact

Jennifer Walsh, PhD

✉ jwalsh@mcw.edu

📞 414-955-7710

Principal Investigator

Jennifer Walsh, PhD

PRINCIPAL INVESTIGATOR

Center for AIDS Intervention Research, Medical College of Wisconsin

Frequently Asked Questions

Who can join the NCT06269081 clinical trial?

This trial is open to participants of all sexes, aged 50 Years or older, studying HIV. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06269081 currently recruiting?

Yes, NCT06269081 is actively recruiting participants. Contact the research team at jwalsh@mcw.edu for enrollment information.

Where is the NCT06269081 trial being conducted?

This trial is being conducted at Milwaukee, United States.

Who is sponsoring the NCT06269081 clinical trial?

NCT06269081 is sponsored by Medical College of Wisconsin. The principal investigator is Jennifer Walsh, PhD at Center for AIDS Intervention Research, Medical College of Wisconsin. The trial plans to enroll 352 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology